Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Lichtenauer, Michael ^a,b   Mildner, Michael ^c   Werba, Gregor ^b,d   Beer, Lucian ^b,d   Hoetzenecker, Konrad ^b,d   Baumgartner, Andrea ^e   Hasun, Matthias ^e   Nickl, Stefanie ^b,d   Mitterbauer, Andreas ^b,d   Zimmermann, Matthias ^b,d   Gyöngyösi, Mariann ^d   Podesser, Bruno Karl ^e   Klepetko, Walter ^d   Ankersmit, Hendrik Jan ^b,d  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHEMOKINE; CHEMOTACTIC FACTOR; CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOTRANSFERASE; PROTEIN P53; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG SCREENING; ENZYME LINKED IMMUNOSPOT ASSAY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE NECROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MACROPHAGE; NONHUMAN; RAT; SCAR; SUPERNATANT; UPREGULATION;

ANIMALS; ANTILYMPHOCYTE SERUM; APOPTOSIS; CARDIOTONIC AGENTS; CELLS, CULTURED; CHEMOKINES; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; RATS; THYMOCYTES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VENTRICULAR REMODELING;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84871463577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052101     Document Type: Article

References (44)

1. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, et al. (2008) Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118: 2057-2062.
2. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221.
3. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, et al. (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355: 1199-1209.
4. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, et al. (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30: 2978-2984.
5. Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD, (2005) The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46: 1799-1802.
6. Ankersmit HJ, Hoetzenecker K, Dietl W, Soleiman A, Horvat R, et al. (2009) Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest 39: 445-456.
7. Lichtenauer M, Mildner M, Baumgartner A, Hasun M, Werba G, et al. (2011) Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 106: 645-655.
8. Lichtenauer M, Mildner M, Hoetzenecker K, Zimmermann M, Podesser BK, et al. (2011) Secretome of apoptotic peripheral blood cells confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Research in Cardiology (in press).
9. Foldes I, Varkonyi S, Solti F, Kocze A, (1970) Effect of antilymphocyte serum on experimental myocardial infarction. Experientia 26: 741-743.
10. Mohty M, (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21: 1387-1394.
11. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, et al. (1998) Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 91: 2360-2368.
12. Ankersmit HJ, Moser B, Zuckermann A, Roth G, Taghavi S, et al. (2002) Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clin Exp Immunol 128: 175-180.
13. Gillet-Hladky S, de Carvalho CM, Bernaud J, Bendahou C, Bloy C, et al. (2006) Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase. Transplantation 82: 965-974.
14. Monti P, Allavena P, Di Carlo V, Piemonti L, (2003) Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol 3: 189-196.
15. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N, (2006) A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 17: 2844-2853.
16. Shimony O, Nagler A, Gellman YN, Refaeli E, Rosenblum N, et al. (2012) Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44. J Clin Immunol 32: 173-188.
17. Boenisch O, Lopez M, Elyaman W, Magee CN, Ahmad U, et al. (2012) Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4(+) T cells and requires the presence of monocytes. Am J Transplant 12: 856-866.
18. Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, et al. (2009) Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 4: e5643.
19. Yang Z, von Ballmoos MW, Faessler D, Voelzmann J, Ortmann J, et al. (2010) Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211: 103-109.
20. Holzinger C, Zuckermann A, Kopp C, Schollhammer A, Imhof M, et al. (1994) Treatment of non-healing skin ulcers with autologous activated mononuclear cells. Eur J Vasc Surg 8: 351-356.
21. Gnecchi M, Zhang Z, Ni A, Dzau VJ, (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
22. Beiras-Fernandez A, Chappell D, Hammer C, Thein E, (2006) Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model. Transpl Immunol 15: 273-279.
23. Beiras-Fernandez A, Thein E, Chappel D, Gallego R, Fernandez-Roel D, et al. (2004) Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model. Transpl Int 17: 453-457.
24. Dubey S, Srivastava A, Nityanand S, (2002) Induction of apoptosis of peripheral blood mononuclear cells by antithymocyte globulin (ATG) in aplastic anemia: an in vivo and in vitro study. Ann Hematol 81: 249-253.
25. Kadl A, Huber J, Gruber F, Bochkov VN, Binder BR, et al. (2002) Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vascul Pharmacol 38: 219-227.
26. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
27. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, et al. (2003) The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107: 1359-1365.
28. Stewart DJ, Kutryk MJ, Fitchett D, Freeman M, Camack N, et al. (2009) VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther 17: 1109-1115.
29. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, et al. (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105: 788-793.
30. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, et al. (2008) Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 29: 2851-2858.
31. Schuh A, Liehn EA, Sasse A, Schneider R, Neuss S, et al. (2009) Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res Cardiol 104: 403-411.
32. Zhang Y, Kohler K, Xu J, Lu D, Braun T, et al. (2011) Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture. J Mol Cell Cardiol 50: 471-478.
33. Mocanu MM, Yellon DM, (2003) p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning. FEBS Lett 555: 302-306.
34. Liu P, Xu B, Cavalieri TA, Hock CE, (2008) Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24 hours of reperfusion. Shock 30: 545-551.
35. Liu H, Pedram A, Kim JK, (2011) Oestrogen prevents cardiomyocyte apoptosis by suppressing p38alpha-mediated activation of p53 and by down-regulating p53 inhibition on p38beta. Cardiovasc Res 89: 119-128.
36. Geng YJ, (2003) Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 1010: 687-697.
37. Crow MT, (2006) Revisiting p53 and its effectors in ischemic heart injury. Cardiovasc Res 70: 401-403.
38. Nahrendorf M, Pittet MJ, Swirski FK, (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437-2445.
39. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, et al. (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204: 3037-3047.
40. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, et al. (2005) CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96: 881-889.
41. Park HJ, Chang K, Park CS, Jang SW, Ihm SH, et al. (2008) Coronary collaterals: the role of MCP-1 during the early phase of acute myocardial infarction. Int J Cardiol 130: 409-413.
42. Liehn EA, Piccinini AM, Koenen RR, Soehnlein O, Adage T, et al. (2010) A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. J Am Coll Cardiol 56: 1847-1857.
43. Becker LC, (2005) Yin and yang of MCP-1. Circ Res 96: 812-814.
44. Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG, (2010) CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176: 2177-2187.